Please check your internet connection and try again.
# Potassium Bromide
## Overview
Potassium bromide (KBr) is an inorganic salt that has been used historically as an anxiolytic and anticonvulsant. Its mechanism of action involves increasing chloride influx into neurons, leading to hyperpolarization and reduced neuronal excitability. It is primarily used in veterinary medicine for long-term management of epilepsy in dogs.
## Primary Indications
* Adjunctive treatment of refractory idiopathic epilepsy in dogs.
* Historically used as a sedative and anticonvulsant in humans, but largely replaced by safer and more effective agents.
## Adult Dosing
* Potassium bromide is **not approved for human use by the FDA**.
* For veterinary use in dogs: Typical starting dose is 10-15 mg/kg orally twice daily, with a target serum bromide concentration of 50-100 mg/dL. Titration is necessary based on clinical response and serum bromide levels.
* Maximum dose and serum concentration should be guided by veterinary specialist recommendations.
## Pediatric Dosing
* There is **no established or recommended pediatric dosing** for potassium bromide due to its unapproved status for human use.
## Dose Adjustments
* In dogs, dose adjustments are based on serum bromide concentrations, typically measured 2-4 weeks after initiation or dose change, and then every 6-12 months or as clinically indicated.
* Renal impairment: Caution is advised as bromide is renally excreted. Dose reduction may be necessary in severe renal insufficiency, though specific guidelines are scarce.
## Contraindications
* Hypersensitivity to potassium bromide.
* Severe renal impairment.
* Use with caution in patients with respiratory depression.
## Adverse Effects
* **Common (especially during initiation or with high doses):** Sedation, ataxia, lethargy, vomiting, anorexia, polyuria, polydipsia.
* **Less common:** Weakness, constipation, pancreatitis, behavioral changes.
* **Severe:** Bromism (neurological signs like stupor, coma, seizures), respiratory depression.
## Key Drug Interactions
* **CNS Depressants:** Additive sedative effects with other sedatives, opioids, benzodiazepines, and anesthetics.
* **Diuretics:** Can decrease serum bromide concentrations by increasing renal excretion.
* **Other Anticonvulsants:** May require dose adjustments of concomitant anticonvulsants (e.g., phenobarbital, levetiracetam) due to potential pharmacokinetic interactions.
## Monitoring
* **Therapeutic Drug Monitoring:** Serum bromide concentrations are crucial for efficacy and safety, particularly in veterinary medicine. Target range is typically 50-100 mg/dL in dogs.
* **Clinical Signs:** Monitor for efficacy (seizure frequency/severity) and adverse effects (sedation, ataxia, gastrointestinal signs).
* **Renal Function:** Periodic assessment of renal function may be warranted, especially in older animals or those with pre-existing renal disease.
## Clinical Pearls
* Potassium bromide has a very long elimination half-life, often measured in weeks, meaning it takes a considerable amount of time to reach steady-state serum concentrations (typically 3-4 months).
* It is often used as an adjunctive therapy rather than monotherapy for epilepsy.
* Onset of action can be slow; patience is required.
* Vomiting can sometimes be mitigated by administering with food.
***
**Disclaimer:** This information is intended for clinical decision support and does not replace professional medical judgment. Always consult the most current prescribing information and relevant literature before making therapeutic decisions. Dosing and recommendations may vary based on individual patient factors and local protocols.
